Racial and ethnic minorities diagnosed with advanced liver cancer have a lower chance of receiving immunotherapy, the most effective treatment for patients with the disease, according to a new study led by Cedars-Sinai Cancer investigators.
Owkin and Cleveland Clinic Develop AI Model that Predicts Liver Cancer Prognosis itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.
Blue Faery Gives Annual Liver Cancer Research Award
Dr. Xin W. Wang, Senior Investigator at the National Cancer Institute, wins Blue Faery Award twice
News provided by
Share this article
Share this article
LOS ANGELES, April 8, 2021 /PRNewswire/ Blue Faery: The Adrienne Wilson Liver Cancer Association is proud to announce the annual Blue Faery Award (BFA) for Excellence in Liver Cancer Research. Primary liver cancer, also known as Hepatocellular Carcinoma (HCC), is the third leading cause of cancer deaths worldwide. Blue Faery created the award to recognize medical professionals who develop innovative research in HCC.
Upon receiving the BFA Dr. Wang stated, I am so thrilled to hear this wonderful news. It s an absolute honor to receive this year s award, especially in the midst of the COVID-19 pandemic and as the recipient who has ever won this award twice. Thanks to the board for recognizing our works.